1. Home
  2. PXED vs PCRX Comparison

PXED vs PCRX Comparison

Compare PXED & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PXED

Phoenix Education Partners Inc.

N/A

Current Price

$30.00

Market Cap

1.1B

Sector

Real Estate

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.05

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXED
PCRX
Founded
1976
2006
Country
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PXED
PCRX
Price
$30.00
$23.05
Analyst Decision
Buy
Strong Buy
Analyst Count
7
6
Target Price
$44.29
$35.33
AVG Volume (30 Days)
80.6K
775.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.45
$6.21
Revenue Next Year
$4.75
$8.26
P/E Ratio
$10.62
$48.25
Revenue Growth
N/A
N/A
52 Week Low
$23.52
$18.80
52 Week High
$47.08
$27.64

Technical Indicators

Market Signals
Indicator
PXED
PCRX
Relative Strength Index (RSI) 52.31 58.70
Support Level $26.69 $20.88
Resistance Level $29.25 $21.60
Average True Range (ATR) 1.67 0.80
MACD 0.08 0.39
Stochastic Oscillator 67.71 93.52

Price Performance

Historical Comparison
PXED
PCRX

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: